BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 2471111)

  • 1. Involvement of spinal monoaminergic pathways in antinociception produced by substance P and neurotensin in rodents.
    Naranjo JR; Arnedo A; Molinero MT; Del Rio J
    Neuropharmacology; 1989 Mar; 28(3):291-8. PubMed ID: 2471111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The synthetic TRH analogue taltirelin exerts modality-specific antinociceptive effects via distinct descending monoaminergic systems.
    Tanabe M; Tokuda Y; Takasu K; Ono K; Honda M; Ono H
    Br J Pharmacol; 2007 Feb; 150(4):403-14. PubMed ID: 17220907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of noradrenaline and 5-hydroxytryptamine depletion on locomotion in the cat.
    Steeves JD; Schmidt BJ; Skovgaard BJ; Jordan LM
    Brain Res; 1980 Mar; 185(2):349-62. PubMed ID: 7357433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
    Howe JR; Yaksh TL
    J Pharmacol Exp Ther; 1982 Feb; 220(2):311-21. PubMed ID: 6120226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA.
    Reader TA; Gauthier P
    J Neural Transm; 1984; 59(3):207-27. PubMed ID: 6234377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
    Pappas B; Ings R; Roberts D
    Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
    Eide PK; Hole K; Berge OG; Broch OJ
    Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lesions to ascending noradrenergic and serotonergic pathways modify antinociception produced by intracerebroventricular administration of morphine.
    Sawynok J; Reid A
    Neuropharmacology; 1989 Feb; 28(2):141-7. PubMed ID: 2497401
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spinal antinociception by adenosine analogs and morphine after intrathecal administration of the neurotoxins capsaicin, 6-hydroxydopamine and 5,7-dihydroxytryptamine.
    Sawynok J; Reid A; Nance D
    J Pharmacol Exp Ther; 1991 Jul; 258(1):370-80. PubMed ID: 1906540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased behavioural response to intrathecal substance P after intracerebroventricular 5,7-dihydroxytryptamine but not after p-chlorophenylalanine administration.
    Eide PK; Hole K; Broch OJ
    Acta Physiol Scand; 1988 Mar; 132(3):419-23. PubMed ID: 2465667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intrathecal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine blocks the antinociception induced by endomorphin-1 and endomorphin-2 given intracerebroventricularly in the mouse.
    Hung KC; Wu HE; Mizoguchi H; Leitermann R; Tseng LF
    J Pharmacol Sci; 2003 Nov; 93(3):299-306. PubMed ID: 14646247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of ascending and descending serotonergic pathways in the antinociceptive effect of baclofen.
    Sawynok J; Reid A
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Apr; 337(4):359-65. PubMed ID: 3405312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-HT agonist induced analgesia modulated by central but not peripheral noradrenaline depletion in rats.
    Minor BG; Archer T; Post C; Jonsson G; Mohammed AK
    J Neural Transm; 1986; 66(3-4):243-59. PubMed ID: 3097248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of monoaminergic involvement in the antinociceptive action of E-2078, morphine and U-50,488E.
    Nakazawa T; Yamanishi Y; Kaneko T
    J Pharmacol Exp Ther; 1991 May; 257(2):748-53. PubMed ID: 1674534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spinal 5-HT pathways and the antinociception induced by intramedullary clonidine in rats.
    Lin MT; Su CF
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Sep; 346(3):333-8. PubMed ID: 1407017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased antinociception by alpha-adrenoceptor drugs after spinal cord noradrenaline depletion.
    Post C; Persson ML; Archer T; Minor BG; Danysz W; Sundström E
    Eur J Pharmacol; 1987 May; 137(1):107-16. PubMed ID: 2886347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contribution of serotonin neurons to the functional recovery after spinal cord injury in rats.
    Hashimoto T; Fukuda N
    Brain Res; 1991 Jan; 539(2):263-70. PubMed ID: 1829012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased behavioural response to intrathecal serotonin after lesion of serotonergic pathways with 5,7-dihydroxytryptamine seems not to be due to depletion of serotonin.
    Eide PK; Hole K
    Acta Physiol Scand; 1988 Oct; 134(2):291-4. PubMed ID: 2976239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of ascending and descending noradrenergic pathways in the antinociceptive effect of baclofen and clonidine.
    Sawynok J; Reid A
    Brain Res; 1986 Oct; 386(1-2):341-50. PubMed ID: 3096496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects of intracisternal 6-hydroxydopamine and of subsequent lesions of the ventrolateral medulla coinciding with the Al group of noradrenaline cells in the rabbit.
    Elliott JM; Stead BH; West MJ; Chalmers J
    J Auton Nerv Syst; 1985; 12(2-3):117-30. PubMed ID: 3923089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.